Inhibrx, Inc. (INBX)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Mark P. Lappe
Employees:
80
11025 N. TORREY PINES ROAD, SUITE 200, LA JOLLA, CA 92037
(858) 795-4220

We are a clinical-stage biotechnology company with a pipeline of novel biologic therapeutic candidates, developed using our protein engineering expertise and proprietary single domain antibody, or sdAb, platform. Our sdAb platform allows us to pursue validated targets with clinical promise, but where other antibody and biologic based approaches have failed.

Data derived from most recent annual or quarterly report
Market Cap 527.236 Million Shares Outstanding39.026 Million Avg 30-day Volume 562.782 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.06
Price to Revenue176.509 Debt to Equity2.4847 EBITDA-72.125 Million
Price to Book Value44.7594 Operating Margin-1038.554 Enterprise Value1.22 Billion
Current Ratio4.733 EPS Growth0 Quick Ratio4.501
1 Yr BETA 1.9491 52-week High/Low 47.9 / 11.56 Profit Margin-1093.9449
Operating Cash Flow Growth-64.1742 Altman Z-Score4.2984 Free Cash Flow to Firm 0
Earnings Report2022-08-09
View SEC Filings from INBX instead.

View recent insider trading info

Inhibrx, Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding INBX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding INBX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

400 total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ECKELMAN BRENDAN P. CHIEF SCIENTIFIC OFFICER

ECKELMAN LIVING TRUST DATED FEBRUARY 5, 2014

  • Officer
  • 10% Owner
 2,715,553 2022-04-05 1

DECK KELLY CHIEF FINANCIAL OFFICER

  • Officer
 20,000 2022-01-11 1

VUORI KRISTIINA MD

  • Director
 30,000 2021-12-07 2

MANHARD KIMBERLY

  • Director
 35,759 2021-06-07 1

FORSYTH DOUGLAS

  • Director
 32,259 2021-06-07 1

KAYYEM JON FAIZ

  • Director
 32,259 2021-06-07 1

WAGNER KLAUS W. CHIEF MEDICAL OFFICER

  • Officer
 215,150 2021-02-16 0

LAPPE MARK CHIEF EXECUTIVE OFFICER

LAPPE FAMILY TRUST

  • Officer
  • Director
  • TO BE VERIFIED
 3,149,714 2021-01-15 0

VIKING GLOBAL INVESTORS LP

VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP

VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC

VIKING GLOBAL OPPORTUNITIES GP LLC

DRAGSA 50 LLC

HALVORSEN OLE ANDREAS

OTT DAVID C.

SHABET ROSE SHARON

  • 10% Owner
 5,305,866 2020-08-26 0

RA CAPITAL MANAGEMENT, L.P.

KOLCHINSKY PETER

SHAH RAJEEV M.

  • 10% Owner
 No longer subject to file 2020-08-21 0

KAYYEM JON FAIZ

JON F. KAYYEM & PAIGE GATES-KAYYEM FAMILY TRUST

  • Director
  • 10% Owner
 3,396,101 2020-08-18 1

DEVERAUX QUINN L.

  • 10% Owner
 2,749,953 2020-08-18 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

ECKELMAN BRENDAN P. - Officer CHIEF SCIENTIFIC OFFICER by the eckelman living trust dated february 5, 2014

ECKELMAN LIVING TRUST DATED FEBRUARY 5, 2014 - > 10% Owner by the eckelman living trust dated february 5, 2014

2022-04-07 16:11:09 -0400 2022-04-05 S 400 $25.04 d 2,555,553 indirect yes -6.7203 -16.0909 0.0 1 -16.0909 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
INHIBRX INC INBX 2022-05-20 22:15:03 UTC 0.3239 0.4961 100000
INHIBRX INC INBX 2022-05-20 21:45:03 UTC 0.3239 0.4961 100000
INHIBRX INC INBX 2022-05-20 21:15:03 UTC 0.3239 0.4961 100000
INHIBRX INC INBX 2022-05-20 20:45:03 UTC 0.3239 0.4961 100000
INHIBRX INC INBX 2022-05-20 20:15:05 UTC 0.3239 0.4961 100000
INHIBRX INC INBX 2022-05-20 19:45:03 UTC 0.3239 0.4961 100000
INHIBRX INC INBX 2022-05-20 19:15:04 UTC 0.3239 0.4961 100000
INHIBRX INC INBX 2022-05-20 18:45:03 UTC 0.3267 0.4933 100000
INHIBRX INC INBX 2022-05-20 18:15:03 UTC 0.3267 0.4933 100000
INHIBRX INC INBX 2022-05-20 17:45:03 UTC 0.3267 0.4933 100000
INHIBRX INC INBX 2022-05-20 17:15:03 UTC 0.3267 0.4933 100000
INHIBRX INC INBX 2022-05-20 16:45:04 UTC 0.3908 0.4292 100000
INHIBRX INC INBX 2022-05-20 16:15:03 UTC 0.3908 0.4292 100000
INHIBRX INC INBX 2022-05-20 15:45:03 UTC 0.3908 0.4292 100000
INHIBRX INC INBX 2022-05-20 15:15:03 UTC 0.3908 0.4292 100000
INHIBRX INC INBX 2022-05-20 14:45:03 UTC 0.3323 0.4877 100000
INHIBRX INC INBX 2022-05-20 14:15:04 UTC 0.3323 0.4877 100000
INHIBRX INC INBX 2022-05-20 13:45:03 UTC 0.3323 0.4877 100000
INHIBRX INC INBX 2022-05-20 13:15:03 UTC 0.3323 0.4877 100000
INHIBRX INC INBX 2022-05-20 12:45:03 UTC 0.3323 0.4877 100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund INBX -96.0 shares, $-2549.76 2022-01-31 N-PORT

Elevate your investments